Search - tctmd.com

Displaying 1 - 20 of 63

Sort: Relevancy | Date

News Conference News ACC 2026

Despite Guidelines, Aspirin Is Used in Fewer Than One in Four High-risk Pregnancies

Yael L. Maxwell

April 03, 2026

News Conference News ACC 2026

Navajo Meal Program Makes Headway in Heart Failure: MUTTON-HF

Caitlin E. Cox

April 02, 2026

News Conference News ACC 2026

GoFreshRx, THRIVE Trials Show BP Benefits of ‘Food as Medicine’

L.A. McKeown

March 31, 2026

News Conference News ACC 2026

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

Michael O'Riordan

March 30, 2026

News Conference News ACC 2026

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

Michael O'Riordan

March 29, 2026

News Conference News ACC 2026

Barbershop Effort Falls Short for Hypertension Prevention in Black Men

Todd Neale

March 29, 2026

News Conference News ACC 2026

KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension

Caitlin E. Cox

March 28, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

Presentation ACC 2025

Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

Presenter: Luke Laffin

March 29, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Conference News ACC 2024

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

L.A. McKeown

April 16, 2024

News Conference News ACC 2024

HUDDLE Up! High BP and Cardiac Changes Prevalent in Retired NFL Players

Michael O'Riordan

April 15, 2024

News Conference News ACC 2024

Vaping Linked to Higher Risk of HFpEF, NIH Data Show

L.A. McKeown

April 12, 2024

News Conference News ACC 2024

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

Shelley Wood

April 11, 2024

Presentation ACC 2024

Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 3-month Primary Results From the Target BP I Randomized Trial

Presenter: David E. Kandzari

April 08, 2024

Presentation ACC 2024

Primary Results from the Phase 2 KARDIA-2 Study

Presenter: Akshay Desai

April 07, 2024

News Conference News ACC 2024

Oral Device Noninferior to CPAP for Reducing BP in Sleep Apnea: CRESCENT

Caitlin E. Cox

April 06, 2024

Presentation ACC 2024

Mandibular Advancement versus CPAP for BP Reduction in OSA and High Cardiovascular Risk

Presenter: Ronald Chi Hang Lee

April 06, 2024

News Conference News ACC 2024

Lack of Sleep Ups Hypertension Risk, Especially for Women

Yael L. Maxwell

April 03, 2024

Advertisement

Despite Guidelines, Aspirin Is Used in Fewer Than One in Four High-risk Pregnancies

Navajo Meal Program Makes Headway in Heart Failure: MUTTON-HF

GoFreshRx, THRIVE Trials Show BP Benefits of ‘Food as Medicine’

SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients

PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV

Barbershop Effort Falls Short for Hypertension Prevention in Black Men

KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension

What’s Going to Be Hot at ACC 2026

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

What’s Going to Be Hot at ACC 2025?

TARGET BP 1: Alcohol-Based RDN Promises Single Treatment for Resistant BP

HUDDLE Up! High BP and Cardiac Changes Prevalent in Retired NFL Players

Vaping Linked to Higher Risk of HFpEF, NIH Data Show

KARDIA-2: Zilebesiran Drops BP on Top of Common Antihypertensives

Effect of Alcohol-mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 3-month Primary Results From the Target BP I Randomized Trial

Primary Results from the Phase 2 KARDIA-2 Study

Oral Device Noninferior to CPAP for Reducing BP in Sleep Apnea: CRESCENT

Mandibular Advancement versus CPAP for BP Reduction in OSA and High Cardiovascular Risk

Lack of Sleep Ups Hypertension Risk, Especially for Women

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content